COLOPLAST A/S/ADR (OTCMKTS:CLPBY) and Wright Medical Group (NASDAQ:WMGI) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, valuation and institutional ownership.
Risk & Volatility
COLOPLAST A/S/ADR has a beta of 0.72, suggesting that its share price is 28% less volatile than the S&P 500. Comparatively, Wright Medical Group has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500.
This table compares COLOPLAST A/S/ADR and Wright Medical Group’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|COLOPLAST A/S/ADR||$2.31 billion||8.45||$564.23 million||$0.27||36.46|
|Wright Medical Group||$744.99 million||3.94||-$202.59 million||($0.22)||-125.09|
COLOPLAST A/S/ADR has higher revenue and earnings than Wright Medical Group. Wright Medical Group is trading at a lower price-to-earnings ratio than COLOPLAST A/S/ADR, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
0.1% of COLOPLAST A/S/ADR shares are owned by institutional investors. 4.0% of Wright Medical Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
COLOPLAST A/S/ADR pays an annual dividend of $0.10 per share and has a dividend yield of 1.0%. Wright Medical Group does not pay a dividend. COLOPLAST A/S/ADR pays out 37.0% of its earnings in the form of a dividend.
This is a breakdown of recent ratings and recommmendations for COLOPLAST A/S/ADR and Wright Medical Group, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Wright Medical Group||0||1||12||0||2.92|
Wright Medical Group has a consensus price target of $31.08, indicating a potential upside of 12.95%. Given Wright Medical Group’s higher probable upside, analysts plainly believe Wright Medical Group is more favorable than COLOPLAST A/S/ADR.
This table compares COLOPLAST A/S/ADR and Wright Medical Group’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Wright Medical Group||-24.74%||-1.94%||-0.50%|
COLOPLAST A/S/ADR beats Wright Medical Group on 10 of the 15 factors compared between the two stocks.
About COLOPLAST A/S/ADR
Coloplast A/S develops and markets intimate healthcare products and services worldwide. The company operates through three segments: Chronic Care, Urology Care, and Wound & Skin Care. It provides ostomy care products for intestinal dysfunction resulting from disease, accident, and congenital disorder. The company's ostomy care products include colostomy, ileostomy, and urostomy bags under the SenSura brand; and SenSura Mio, a colostomy product with elastic adhesive that fits individual body shapes, as well as ostomy accessories under the Brava brand. It also offers urology care products for people suffering from diseases and symptoms of the urinary system, pelvic floor prolapse, and the male reproductive system, such as urinary incontinence, kidney stones, enlarged prostate, and impotence. The company's disposable surgical devices include prostate catheters and stents used for urological and gynecological applications before, during, and after surgery under the Porgès brand; vaginal slings to restore continence; synthetic mesh products to treat weak pelvic floor; and penile implants for men. In addition, it provides continence care products, such as SpeediCath catheters that offer catherisation for both genders; Peristeen, an anal irrigation system for controlled emptying of the bowels; and Conveen Active urine bags. Further, the company offers wound care products, such as foam dressings under the Biatain brand and hydrocolloid dressing under the Comfeel brand, as well as skin care products, such as disinfectant liquids or creams used to protect and treat the skin and to clean wounds. Additionally, it offers Interdry, a textile placed in a skin fold to absorb moisture for treatment and prevention of skin fold problems, such as fungal infections, damaged skin, or odour nuisance. The company supplies its products to hospitals, institutions, wholesalers, and pharmacies; and directly to users. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.
About Wright Medical Group
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells extremities and biologics products. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries, as well as other ancillary products. The company primarily offers its products to orthopaedic, trauma, and podiatric surgeons. It markets and sells its products through direct sales representatives and independent sales agencies in the United States, as well as direct sales offices and distributors in approximately 50 countries. The company was founded in 1999 and is headquartered in Amsterdam, the Netherlands.
Receive News & Ratings for COLOPLAST A/S/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COLOPLAST A/S/ADR and related companies with MarketBeat.com's FREE daily email newsletter.